PHAT
Phathom Pharmaceuticals Inc
6.70$
-3.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | 24.5% | 14.4% | 12.9% | |
| – | – | – | – | – | 75.5% | 85.6% | 87.1% | |
| – | – | – | – | – | 7,316.6% | 61.7% | 18.7% | |
| – | – | – | – | – | 17,291.5% | 526.1% | 159.7% | |
| – | – | – | – | – | 24,608.1% | 587.8% | 178.5% | |
| – | – | – | – | – | -24,532.6% | -502.2% | -91.4% | |
| – | – | – | – | – | 6,153.7% | 130.3% | 38.9% | |
| – | – | – | – | – | -29,558.9% | -605.1% | -126.3% | |
| – | – | – | – | – | 6,126.1% | – | – | |
| – | – | – | – | – | -29,558.9% | -605.1% | -126.3% | |
| – | – | – | – | – | -23,321.0% | -473.3% | -87.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.